—
The latest market report published by Credence Research, Inc. “Global Interventional Pulmonology Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global interventional pulmonology market is expected to reach from US$ 1,145.6 Mn in 2017 to US$ 1,747.0 Mn by 2026 expanding at a CAGR of 4.8% from 2018 to 2026.Market Insights
World Health Organization (WHO), has states that lung cancer is the biggest cause of death associated with cancer worldwide, approximately after every 30 seconds someone dies due to ling cancer worldwide. The major risk factors associated with lung cancer are tobacco smoking, air pollution, radiation therapy, genetic factors and immunosuppression. Interventional pulmonology is useful in the treatment and diagnosis of pulmonary disorders such as lung cancer, COPD, pulmonary fibrosis, oesophageal cancer etc.
The complete report is available at https://www.credenceresearch.com/report/interventional-pulmonology-market
These procedures have advantageous features such as quick recovery, minimally side effects and shorter hospital stay. Proactive government policies to curb the mortality rate associated with lung cancer will provide a positive impetus to the interventional pulmonology market growth.
Flexible bronchoscopy has completed replaced the rigid bronchoscopy procedures and is currently the leading the procedure segment in interventional pulmonology market. The inherent features associated with this procedure are precise sample collection and accurate diagnosis. It has been widely employed by pulmonologists to diagnose different stages of lung cancer, tumor debulking procedures and in treating airway stenosis. Pleuroscopy has gained tremendous attraction in the recent times due to its popularity as an alternative to video assisted thoracoscopic surgery (VATS), which is widely employed in diagnosis of pleural effusion of unknown etiology. It is a minimally invasive surgical procedure which has gained success in the accurate diagnosis of tuberculosis effusion.
Get Sample with details report (Free) @ https://www.credenceresearch.com/sample-request/59657
North America with a market share of 35% is the supreme leader in the regional segment for interventional pulmonology market. The primary factors responsible for its overwhelming dominance are rising prevalence of lung cancer and rising public health awareness. Affordable reimbursement scenario for interventional pulmonology procedures further consolidates market growth in North America region. According to the research citings as presented by Lung Cancer Europe (LUCE), in 2018 approximately 310,000 adults have been reported to be diagnosed with lung cancer. Europe is in second position with 30% market share primarily due to increasing air pollution and significant rise in tobacco smoking among young population. Asia Pacific currently represents 15% share on account of supportive regulatory environment provided by regional healthcare bodies. Rampant growth in the establishment of subsidiaries and retail outlets of pioneers such as Terumo Corporation, Boston Scientific Corporation, Karl Storz etc.
Medical device companies competing in interventional pulmonology market are Boston Scientific Corporation, BTG, Plc., Ethicon, Inc., ENDO-FLEX GmbH, HealthTronics, Inc., Karl Storz, Medtronic, Plc., Pulmonx, Inc., Terumo Corporation and Varian Medical Systems, Inc.
Key Market Movements:
Rising prevalence of pulmonary disorders
Technological advancement in the sophisticated tools designed to perform diagnosis and treatment by interventional pulmonology procedures
Affordable reimbursement scenario and growing public health awareness
Browse the full report Interventional Pulmonology Market - Growth, Future Prospects, Competitive Analysis, 2018 – 2026 at https://www.credenceresearch.com/report/interventional-pulmonology-market
TOC :
Chapter 1. Preface
...............
Chapter 2. Executive Summary
...............
Chapter 3. Interventional Pulmonology Market: Dynamics and Future Outlook
...............
Chapter 4. Global Interventional Pulmonology Market, by Procedure
4.1. Overview
4.2. Flexible Bronchoscopy
4.3. Rigid Bronchoscopy
4.4. Bronchoalveolar Lavage
4.5. Lung Biopsy
4.6. Bronchial Stent
4.7. Balloon Bronchoplasty
4.8. Pleuroscopy
4.9. Others
Chapter 5. Global Interventional Pulmonology Market, by Geography
5.1. Overview
5.2. North America Interventional Pulmonology Market Analysis, 2016 – 2026
5.2.1. North America Interventional Pulmonology Market, by Procedure, 2016 – 2026 (US$ Mn)
5.2.2. North America Interventional Pulmonology Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Interventional Pulmonology Market Analysis, 2016 – 2026
5.3.1. Europe Interventional Pulmonology Market, by Procedure, 2016 – 2026 (US$ Mn)
5.3.2. Europe Interventional Pulmonology Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Interventional Pulmonology Market Analysis, 2016 – 2026
5.4.1. Asia Pacific Interventional Pulmonology Market, by Procedure, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific Interventional Pulmonology Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific
5.5. Latin America Interventional Pulmonology Market Analysis, 2016 – 2026
5.5.1. Latin America Interventional Pulmonology Market, by Procedure, 2016 – 2026 (US$ Mn)
5.5.2. Latin America Interventional Pulmonology Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa Interventional Pulmonology Market Analysis, 2016 – 2026
5.6.1. MEA Interventional Pulmonology Market, by Procedure, 2016 – 2026 (US$ Mn)
5.6.2. MEA Interventional Pulmonology Market, by Region, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA
Chapter 6. Company Profiles
6.1. Boston Scientific Corporation
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. News Coverage
6.2. BTG, plc.
6.3. Ethicon, Inc.
6.4. ENDO-FLEX GmbH.
6.5. HealthTronics, Inc.
6.6. Karl Storz
6.7. Medtronic, plc.
6.8. Pulmonx, Inc.
6.9. Terumo Corporation
6.10. Varian Medical Systems, Inc.
...............................toc continued
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
More Related Reports by Credence Research;
Medical Imaging Equipment Market By Product Type (X-Ray Devices, Ultrasound Systems, Computer Tomography (CT) Scanners, Magnetic Resonance Imaging (MRI) Equipment, Nuclear Imaging Equipment), By Technology (X-Ray Devices, Ultrasound Systems, Computer Tomography (CT) Scanners, Magnetic Resonance Imaging (MRI) Equipment, Nuclear Imaging Equipment) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2022
Breast Biopsy Devices Market By Biopsy Type (Fine Needle Aspiration Biopsy (FNAB), Core Needle Biopsy (CNB), Vacuum Assisted Breast Biopsy (VABB), Incisional And Excisional Breast Biopsy) By Products (Needle Based Biopsy Guns, Biopsy Guidance Systems, Biopsy Forceps, Biopsy Needles, Others) By Guidance Modality (Stereotactic X-ray Guided Biopsy, Ultrasound Guided Biopsy, Mri Guided Biopsy, Without Imaging Guidance Biopsy) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026
Medical Tapes & Bandages Market - Growth, Future Prospects & Competitive Analysis, 2018-2026
Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research Inc
Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US
Phone: +18003618290
Website: https://www.credenceresearch.com
Release ID: 503152
Google
RSS